Nexium (Esomeprazole Sodium)

Esomeprazole, the active ingredient in Nexium, is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid production and is employed in the management of acid‑related gastrointestinal disorders in adult patients requiring parenteral therapy.

GNH USA supplies Nexium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable cold‑chain logistics where required, with regulatory approvals across the European Union and other major markets.

Nexium (esomeprazole) is a proton pump inhibitor used to treat several acid‑related gastrointestinal conditions.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief by reducing gastric acid exposure to the esophagus. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - NSAID‑induced gastric ulcer: protects the gastric mucosa from ulceration caused by non‑steroidal anti‑inflammatory drugs. - Helicobacter pylori eradication (as part of combination therapy): enhances bacterial clearance when used with antibiotics. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Common Side Effects: - Headache: mild to moderate pain often reported during therapy. - Diarrhea: loose stools occurring in a subset of patients. - Nausea: feeling of queasiness without vomiting. - Abdominal pain: discomfort or cramping in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Anaphylaxis: life‑threatening allergic reaction with rash, swelling, and respiratory distress. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: severe skin blistering and detachment. - Hepatic enzyme elevation: increased ALT/AST indicating liver stress. - Hypomagnesemia: low serum magnesium levels causing muscle weakness or arrhythmias. - Bone fracture risk: long‑term use may reduce bone mineral density.

Before initiating therapy, consider the following precautions: - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: use with caution in patients with liver disease. - Elderly patients: assess fracture risk due to potential bone density loss. - Pregnancy: safety category unknown; weigh potential benefits against risks. - Drug interactions: review concomitant medications for possible interactions. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Esomeprazole may interact with several medications; monitor patients accordingly.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption leading to subtherapeutic antiviral levels. - Ketoconazole: reduced absorption and efficacy of the antifungal.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring more frequent coagulation monitoring. - Digoxin: may raise serum digoxin concentrations, necessitating dose adjustment. - Methotrexate: reduced clearance can elevate toxicity risk, especially at high doses.